GlassScriptPhysician profile
Viktor Baltaytis
NPI 1932187085
$1,330.11
in general payments reported to CMS, 2019-2025
20 companies · $370 in 2025
The $370 reported for 2025 was more than what 89% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $94.36 · 2021: $36.34 · 2022: $256 · 2023: $118 · 2024: $277 · 2025: $370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $765.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $260.80 | 2022-2025 | Impella |
| Edwards Lifesciences Corporation | $180.43 | 2023-2025 | Sapien 3 Ultra Resilia |
| Cumberland Pharmaceuticals, INC. | $172.96 | 2019-2025 | Caldolor |
| Chiesi USA, INC. | $152.87 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $138.85 | 2019-2025 | Bridion, Dificid, Zinplava |
| Takeda Pharmaceuticals U.S.A., INC. | $96.19 | 2023-2025 | Entyvio |
| Phathom Pharmaceuticals, INC. | $66.39 | 2024-2025 | Voquezna |
| Csl Behring | $43.21 | 2019-2022 | |
| Atricure, INC. | $37.13 | 2024 | |
| Janssen Biotech, INC. | $34.45 | 2023 | Stelara, Remicade, Simponi Aria |
| Lilly USA, LLC | $30.72 | 2024-2025 | Omvoh |
| Pacira Pharmaceuticals Incorporated | $17.76 | 2025 | Exparel |
| Heron Therapeutics, INC. | $13.78 | 2022 | |
| Baudax Bio INC. | $13.63 | 2020 | |
| Redhill Biopharma INC. | $13.25 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $12.22 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.10 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $11.95 | 2019 | |
| Boston Scientific Corporation | $11.17 | 2019 | |
| Nuwellis, INC. | $10.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Viktor Baltaytis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.